Trevi Therapeutics (NASDAQ:TRVI) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.04, FiscalAI reports. Trevi Therapeutics Stock Performance Shares of TRVI stock traded up $0.03 during mid-day trading on Tuesday, hitting $11.19. 1,016,020 shares of the stock […]
17 Mar 17:16 · The Cerbat Gem